Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NexgenRx Inc NEGXF


Primary Symbol: V.NXG

Financial Services Insurance Brokers
NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. It offers plan sponsors, providers and patient support program... see more

Recent & Breaking News (TSXV:NXG)

NexgenRx Announces 2021 Year End Results with Significant Revenue Growth and $3.5m EBITDA

Accesswire March 25, 2022

NexgenRx Announces Declaration of Dividend

Accesswire January 20, 2022

NexgenRx Announces Financial Results for Q3 2021 with Increased Positive EBITDA and Free Cash Flow

Accesswire November 19, 2021

NexgenRx Announces Expansion of Leadership Team

Accesswire August 24, 2021

NexgenRx Announces Financial Results for Q2 2021 With Continued Growth in Revenues and Adjusted EBITDA

Accesswire August 18, 2021

NexgenRx Announces Annual Meeting Results

Accesswire June 10, 2021

NexgenRx Announces Financial Results for Q1 2021 with Continued EBITDA and Net Profit Growth

Accesswire May 26, 2021

NexgenRx Announces 2020 Year End Results with Record EBITDA and Net Profit

Accesswire March 31, 2021

NexgenRx Announces Retirement of all CBA/MYB Outstanding Indebtedness and Stock Option Grants

Accesswire March 5, 2021

NexgenRx Announces Q3 2020 Results

Accesswire November 19, 2020

NexgenRx Announces 2020 Q2 Interim Results

Accesswire August 20, 2020

NexgenRx Announces Amendment of Share Capital, Creation and Issuance of Series 1 Preferred Shares

Accesswire July 9, 2020

NexgenRx Announces 2020 Q1 Interim Results

Accesswire May 11, 2020

NexgenRx Announces 2019 Annual Results

Accesswire April 9, 2020

NexgenRx Announces Q3 2019 Results

Accesswire November 21, 2019

NexgenRx Announces Debt Re-Structuring

Accesswire October 11, 2019

NexgenRx Announces Q2 2019 Results

Accesswire August 16, 2019

NexgenRx Announces Director Retirement

Accesswire July 5, 2019

NexgenRx Announces Q1 2019 Financials and Annual Meeting Results

Accesswire May 29, 2019

NexgenRx Announces Q3 2017 Results

Filing Services Canada November 29, 2017